Prosecution Insights
Last updated: July 05, 2026
Application No. 18/885,813

DURABLE UNDERWEAR ADAPTED FOR USE WITH ABSORBENT COMPONENT

Non-Final OA §DP
Filed
Sep 16, 2024
Priority
Oct 07, 2019 — provisional 62/911,435 +1 more
Examiner
SU, SUSAN SHAN
Art Unit
Tech Center
Assignee
The Procter & Gamble Company
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
1y 4m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
797 granted / 1112 resolved
+11.7% vs TC avg
Strong +23% interview lift
Without
With
+23.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
46 currently pending
Career history
1151
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
80.1%
+40.1% vs TC avg
§102
4.3%
-35.7% vs TC avg
§112
10.4%
-29.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1112 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-19 are pending and examined on the merits. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-19 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-3, 5-12, and 15-19 of U.S. Patent No. 12,121,431. Although the claims at issue are not identical, they are not patentably distinct from each other because the patented claim 1 recites all of the limitations in the current claims 1-4 plus the additional limitation that the crotch portion has a minimum width of 8 cm. The patented claims 2-3, 5-12, and 15-19 read on the current claims 5-19, respectively. Allowable Subject Matter Claims 1-19 are contain allowable subject matter. Note the nonstatutory double patenting rejection of all claims. The following is a statement of reasons for the indication of allowable subject matter: No prior art is found to disclose, inter alia, a crotch portion of a durable underwear comprising a Poisson Contraction Effect upon lateral stretching, i.e., a ratio between the elongation in one direction and the contraction in a perpendicular direction, to have the claimed range of 0.40 or less. Dunbar (US 2014/0039432) is considered to be the closest prior art. Dunbar discloses a durable underwear brief panty (e.g., 100) adapted to accommodate an absorbent component (e.g., [0010] "the undergarment includes one or more pad pockets that each allows a pad to be inserted therein"), comprising: a front waist portion (seen on the left in Fig. 1A) with a front waist edge and left and right front leg opening edges; a rear waist portion (see in the middle in Fig. 1A) with a rear waist edge and left and right rear leg opening edges; a crotch portion (crotch area 110) with a forward portion meeting the front waist portion, a rearward portion meeting the rear waist portion, and left and right crotch leg opening edges; and left and right hip side portions joining the front waist portion to the rear waist portion and thereby forming a waist opening (waist opening 106) with a waist opening edge comprising the front waist edge and the rear waist edge, and left and right leg openings (a pair of leg openings 108) each comprising a respective left or right front leg opening edge, crotch leg opening edge and rear leg opening edge; wherein, when the panty is in an opened configuration in which the front waist portion and rear waist portion are separated at the hip side portions, the panty has a longitudinal axis and a lateral axis, with an intersection thereof, the intersection occurring in the crotch portion. Dunbar does not disclose a Poisson Contraction Effect and do not recognize that a fabric has anisotropic properties such that elongation in one direction would cause contraction in a perpendicular direction. Anderson et al. (US 2005/0142331) discloses a nonwoven web having low Poisson ratio of less than 0.3 ([0092]) but does not disclose where and how such a nonwoven may be used. Redwine et al. (US 6,393,621) discloses an undergarment designed to be used with an absorbent pad, wherein the undergarment crotch region can comprise woven, nonwoven, or knit material (Col. 11 lines 50-51) and has a lateral stretch modulus of 0.04 gf/mm to 1.97 gf/mm (Col. 11 lines 40-43), which is close to but outside of the currently claimed range. Redwine does not disclose a longitudinal stretch modulus for the entire crotch region but instead discloses a longitudinal stretch control member (52) used in the crotch region, wherein the control member has a longitudinal stretch modulus of 1.97 gf/mm to 19.7 gf/mm (Col. 12 lines 25-29). It is not readily clear how this longitudinal stretch modulus of a single control member would affect that of the crotch portion. Redwine also discloses that angled stretch control members (54) are used in the crotch region to creates forces in the crotch panel (50) such that “Poisson narrowing is minimized” (col. 15 lines 42-45). Redwine does not disclose a longitudinal or lateral elongation of the crotch portion. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SUSAN S SU whose telephone number is (408)918-7575. The examiner can normally be reached M-F 9:00 - 5:00 Pacific. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rebecca Eisenberg can be reached at 571-270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SUSAN S SU/ Primary Examiner, Art Unit 3781 6 June 2026
Read full office action

Prosecution Timeline

Sep 16, 2024
Application Filed
Jun 10, 2026
Non-Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661276
ABSORBENT STRUCTURES AND METHODS FOR MANUFACTURING ABSORBENT STRUCTURES
3y 4m to grant Granted Jun 23, 2026
Patent 12653733
Disposable Absorbent Article
4y 1m to grant Granted Jun 16, 2026
Patent 12653731
ABSORBENT STRUCTURES AND METHODS FOR MANUFACTURING ABSORBENT STRUCTURES
3y 3m to grant Granted Jun 16, 2026
Patent 12653931
METHODS AND DEVICES FOR MEDICAL IMPLANTS
2y 10m to grant Granted Jun 16, 2026
Patent 12642743
SEPTUM HOLDERS FOR USE IN SYRINGE CONNECTORS
2y 10m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
95%
With Interview (+23.4%)
3y 1m (~1y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1112 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month